What is the appropriate treatment for acute epididymitis?

Treatment of Acute Epididymitis

For sexually active men under 35 years: treat with ceftriaxone 1 g IM single dose PLUS doxycycline 100 mg orally twice daily for 10 days; for men over 35 years or those with urinary tract instrumentation: treat with a fluoroquinolone (levofloxacin or ofloxacin) alone for 10 days. 1, 2

Age-Based Treatment Algorithm

The treatment approach hinges on patient age and sexual activity, as these factors predict the causative organism:

Men < 35 Years (Sexually Active)

• Primary pathogens: Chlamydia trachomatis and Neisseria gonorrhoeae 3, 4, 5
• Recommended regimen:
  • Ceftriaxone 1 g IM (or IV) single dose 1, 2
  • PLUS Doxycycline 100 mg orally twice daily for 10 days 3, 4, 1

Note: The ceftriaxone dose has been increased from the older 250 mg recommendation to 1 g in the most recent 2024 European guidelines 1, 2. This reflects rising antimicrobial resistance patterns in gonorrhea.

Men Who Practice Insertive Anal Intercourse

• Additional pathogen: Enteric organisms (particularly E. coli) 3, 5
• Recommended regimen:
  • Ceftriaxone 1 g IM single dose
  • PLUS Levofloxacin 500 mg orally daily for 10 days OR Ofloxacin 300 mg orally twice daily for 10 days 1, 5

This dual coverage addresses both sexually transmitted infections and enteric bacteria.

Men > 35 Years or Recent Urinary Instrumentation

• Primary pathogens: Gram-negative enteric organisms, predominantly E. coli 3, 4, 6
• Recommended regimen:
  • Levofloxacin 500 mg orally daily for 10 days OR Ofloxacin 300 mg orally twice daily for 10 days 4, 1, 5

Fluoroquinolone monotherapy is sufficient as sexually transmitted infections are less likely in this population.

Critical Diagnostic Considerations

Before initiating treatment, always rule out testicular torsion first—this is a surgical emergency where delay causes testicular loss 3, 4. Torsion is more common in adolescents and presents with sudden severe pain without signs of infection or urethritis 3.

Essential Workup

• Urethral Gram stain or intraurethral swab for urethritis (≥5 PMNs per oil immersion field) 3, 4
• Nucleic acid amplification test (NAAT) for N. gonorrhoeae and C. trachomatis on urethral swab or first-void urine 3, 4, 1
• Urine culture and Gram stain if urethral testing is negative 3, 4
• HIV testing and syphilis serology 3, 4

Important caveat: Research shows that even with comprehensive testing, a causative pathogen is identified in only 88% of antibiotic-naive patients and 51% of pretreated patients 6. However, sexually transmitted infections are found in 14% of cases and are not restricted to younger age groups 6, challenging the traditional age-based paradigm.

Adjunctive Therapy

Regardless of antimicrobial choice, all patients require:

• Bed rest until fever and inflammation subside 3, 4
• Scrotal elevation 3, 4
• Analgesics 3, 4

Follow-Up and Treatment Failure

Reassess within 3 days if no improvement 3, 4, 1. Failure to improve mandates reevaluation of both diagnosis and therapy. Consider alternative diagnoses including:

• Testicular torsion (if not already ruled out)
• Testicular tumor
• Abscess formation
• Testicular infarction
• Tuberculous or fungal epididymitis 3, 4

Risk factors for poor outcomes include fever, elevated CRP, and decreased testicular blood flow on ultrasound 7. These patients may require hospitalization and more aggressive management.

Hospitalization Criteria

Consider admission when 3, 4:

• Severe pain suggesting alternative diagnoses (torsion, infarction, abscess)
• Fever present
• Concern for medication noncompliance
• Immunocompromised status (HIV-infected patients may require more aggressive therapy) 3, 4

Partner Management

For sexually transmitted epididymitis: Refer all sexual partners from the preceding 60 days for evaluation and treatment 3, 4. Instruct patients to abstain from sexual intercourse until both patient and partners complete therapy and are asymptomatic 3, 4.

Evidence Quality and Practice Gaps

Critical limitation: Despite being a common condition, there is remarkably sparse direct trial data on antimicrobial treatments for acute epididymitis 8, 9. A 2018 systematic review identified only 1 study meeting inclusion criteria out of 1534 records 9. Current recommendations are largely derived from previous guidance, knowledge of antimicrobial activity, and treatment outcomes in uncomplicated infections 8.

Real-world adherence to guidelines is poor—studies show that less than 35% of patients receive appropriate CDC-recommended workup, and many are prescribed antibiotics not in accordance with guidelines 10, 11. Ciprofloxacin, commonly prescribed by 71% of urologists in one survey 11, is not optimal for chlamydial infection and should be avoided when sexually transmitted pathogens are suspected.

Special Populations

HIV-infected patients: Use the same treatment regimens as HIV-negative patients for uncomplicated epididymitis 3, 4. However, fungi and mycobacteria are more likely causes in immunosuppressed patients 3, 4.

Pediatric patients (< 14 years): Etiology is largely unknown but reflux of urine into ejaculatory ducts is considered most common 5. Bacterial etiology is documented in only 6.6% of cases 10.